Acute Coronary Syndromes (ACS) refer to a spectrum of urgent, life-threatening conditions caused by sudden reduction or blockage of blood flow to the heart, typically due to plaque rupture and thrombus formation in coronary arteries. ACS includes unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Rapid diagnosis and treatment are critical to minimize heart muscle damage and improve survival. Management involves antiplatelet and anticoagulant therapy, reperfusion strategies like percutaneous coronary intervention (PCI), and long-term secondary prevention. Risk stratification using biomarkers, ECG, and cardiac imaging guides therapeutic decisions. Research in ACS focuses on precision medicine, novel antithrombotic agents, and post-event rehabilitation. Effective ACS management relies on coordinated emergency response, evidence-based protocols, and patient education to reduce morbidity and prevent recurrent cardiac events.
| 2-5 Days | Initial Quality & Plagiarism Check |
| 25-35 Days |
Peer Review Feedback |
| 45-60 Days | Total article processing time |
| English | Publication Language |
| Single-Blind | Peer-Review Model |
| 17% | Acceptance Rate |
| <18% | Similarity Screening Guideline |
| Open Access | Access Model |
All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.